WallStreetZenWallStreetZen

NASDAQ: QLGN
Qualigen Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their QLGN stock forecasts and price targets.

Forecast return on equity

Is QLGN forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is QLGN forecast to generate an efficient return on assets?

Company
-30.99%
Industry
12.84%
QLGN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

QLGN earnings per share forecast

What is QLGN's earnings per share in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.72

QLGN revenue forecast

What is QLGN's revenue in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0

QLGN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
QLGN$2.85N/AN/A
PTIX$2.57N/AN/A
CANF$0.42$11.00+2,519.05%Strong Buy
SILO$0.54N/AN/A
APVO$1.55N/AN/A
View Top Biotech Stocks

Qualigen Therapeutics Stock Forecast FAQ

What is QLGN's earnings growth forecast for 2025-2025?

(NASDAQ: QLGN) Qualigen Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Qualigen Therapeutics's earnings in 2025 is -$7,012,231.

In 2025, QLGN is forecast to generate -$1,227,845 in earnings, with the lowest earnings forecast at -$1,179,694 and the highest earnings forecast at -$1,263,958.

If you're new to stock investing, here's how to buy Qualigen Therapeutics stock.

What is QLGN's revenue growth forecast for 2025-2025?

(NASDAQ: QLGN) Qualigen Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Qualigen Therapeutics's revenue in 2025 is $0.

In 2025, QLGN is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is QLGN's forecast return on assets (ROA) for 2025-2025?

(NASDAQ: QLGN) forecast ROA is -30.99%, which is lower than the forecast US Biotechnology industry average of 12.84%.

What is QLGN's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: QLGN) Qualigen Therapeutics's current Earnings Per Share (EPS) is -$0.14. In 2025, QLGN's EPS is forecast to hit -$0.72 (min: -$0.70, max: -$0.75).

What is QLGN's forecast return on equity (ROE) for 2025-2025?

(NASDAQ: QLGN) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.